Skip to content

Offline expansion of healthtech platform Livlong 365, managed by OPD, plans to inject ₹100 Crores, with a goal of establishing 100 branches by the year 2027.

Livlong 365 aims to set up a presence within urban areas that have a city population exceeding 15 hundred thousand

Offline growth planned for Livlong 365 healthtech platform as they aim to invest rupees one hundred...
Offline growth planned for Livlong 365 healthtech platform as they aim to invest rupees one hundred crore, with aspirations to establish one hundred branches by the year 2027.

Offline expansion of healthtech platform Livlong 365, managed by OPD, plans to inject ₹100 Crores, with a goal of establishing 100 branches by the year 2027.

In a series of significant developments in the Indian healthcare sector, two major partnerships have been announced, and a new appointment has been made at ShardaCare Healthcity and Sharda Hospital.

Firstly, the Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with Pfizer. The aim of this collaboration is to accelerate the lab-to-market journey of healthcare products. However, further details about the specific nature of the partnership and the products involved have not been disclosed.

Secondly, Danone India has partnered with the Government of Maharashtra to drive awareness about iron deficiency and protein intake among Mumbaikars. This initiative, though lacking in specific details, is a significant step towards promoting health and wellness in the bustling city.

Meanwhile, ShardaCare Healthcity and Sharda Hospital have appointed Sandeep Dogra as their Group Chief Operating Officer (COO). With over 25 years of healthcare leadership experience, Dogra has previously served as the Chief Revenue Officer (CRO) since April 2025. In his new role, he will oversee operations, strengthen teams, and advance the integrated healthcare ecosystem of ShardaCare Healthcity.

It's worth noting that these developments do not seem to be directly related to recent additions to the World Health Organization's Essential Medicines List (EML) or to the topic of medication waste. Furthermore, there is no apparent connection between the DPIIT-Pfizer MoU and kidney-preserving cancer care, or between the Danone India-Government of Maharashtra alliance and the specific context of health policies.

These collaborations and appointments underscore the ongoing efforts to improve healthcare in India, with a focus on awareness, innovation, and operational efficiency. As more details about these initiatives unfold, we can expect to gain a clearer understanding of their impact on the health and wellbeing of the nation.

Read also: